补肾活血治疗原发性闭角型青光眼的临床研究

摘要

目的：探讨补肾活血在治疗闭角型青光眼中的临床效果。方法选取原发性闭角型青光眼患者68例（128只病眼），随机将其均分成实验组和对照组，各34例。实验组采用补肾活血的杞菊地黄丸合复方丹参片联合甲钴胺片方法治疗，对照组采用单纯的口服甲钴胺片，连续用药6个月，并进行随访1年，比较2组疗效差异。结果实验组患者治疗后MS、MD及中医症候积分分别为（22.134±3.278）、（6.129±3.362）、（4.400±3.193），对照组患者三项指标分别为（20.134±3.312）、（5.746±3.758）、（5.300±2.618），2组对比差异有统计学意义（P＜0.05）；实验组65只眼44只视力进步，进步率67.7%，对照组63只眼26只视力进步，进步率41.3%，差异有统计学意义（P＜0.05）。结论在治疗原发性闭角型青光眼时应用补肾活血中药疗效较好，值得在临床上推广。%ObjectiveTo discuss and analyze theclinical results in treating of angle closure glaucoma by promoting blood circulation.Methods Chose 68 patients who were checked with primary angle-closure glaucoma, and dividedthem (128 eyes disease) randomly into experimental group and control group. The experimental group were given therapy, cobalt aminecombined with blood circulation promoting method, while the control group adopted a simple oral cobalt amine. Continuous medication last for six months, and patients included were followed up for a year to compared the differences.ResultsThe MS, MD, and TCM symptom scores of patients in experimental group were(22.134±3.278),(6.129±3.362),(4.400±3.193), which were(20.134±3.312),(5.746±3.758),(5.300±2.618) in control group. The difference were statistically significant (P< 0.05); Patients in experimental group shew a higher vision improvementrate (67.7%) than the control group (41.3%), and the difference was statistically signiifcant (P<0.05).ConclusionIn treatment of primary angle-closure glaucoma, application of traditional Chinese medicine could make a better efifcacy in clinic, which was worth promoting.